Affecting as many as 500,000 Americans, bronchiectasis (BE) is an under-diagnosed chronic lung disease that causes permanent airway damage and retained secretions. Often misdiagnosed as asthma or COPD, BE requires a range of therapeutic interventions, including airway clearance therapy. In this on-demand webinar hosted by RT Magazine, a panel of respiratory and pulmonary experts discussed effective and successful strategies for treating bronchiectasis, including:
- The clinical impact of bronchiectasis;
- Treatment options, including pharmacological therapy and airway clearance therapy; and
- A look at established hospital bronchiectasis programs for successful tips on creating a new program.
Register now to watch the on-demand recording, below.
This webinar was generously sponsored by Tactile Medical.
